APTEVO RESEARCH AND DEVELOPMENT LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for APTEVO RESEARCH AND DEVELOPMENT LLC.The latest application filed is for "prostate-specific membrane antigen binding proteins and related compositions and methods".

Company Profile

14.11.16

APTEVO RESEARCH AND DEVELOPMENT LLC - Seattle WA US
APTEVO RESEARCH AND DEVELOPMENT LLC - Seattie WA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prostate-specific Membrane Antigen Binding Proteins And Related Compositions And Methods App 20210095046 - BLANKENSHIP; John W. ; et al.	2021-04-01
Single-chain Multivalent Binding Proteins With Effector Function App 20200354447 - THOMPSON; Peter Armstrong ; et al.	2020-11-12
Antigen Binding Proteins Binding To 5t4 And 4-1bb And Related Compositions And Methods App 20200223933A1 -	2020-07-16
Methods of treatment of CD123 overexpressing disorders Grant 10,676,533 - Hernandez-Hoyos , et al.	2020-06-09
Cd123 Binding Proteins And Related Compositions And Methods App 20200165346 - Hernandez-Hoyos; Gabriela ; et al.	2020-05-28
Oncofetal Antigen Binding Proteins And Related Compositions And Methods App 20190382503 - Bienvenue; David ; et al.	2019-12-19
B-cell Reduction Using Cd37-specific And Cd20-specific Binding Molecules App 20190290755 - Grosmaire; Laura Sue ; et al.	2019-09-26
CD37 immunotherapeutics and uses thereof Grant 10,307,481 - Grosmaire , et al.	2019-06-04
Oncofetal antigen binding proteins and related compositions and methods Grant 10,239,949 - Bienvenue , et al.	2019-03-26
Cd123 Binding Proteins And Related Compositions And Methods App 20190071513 - Hernandez-Hoyos; Gabriela ; et al.	2019-03-07
CD3 binding polypeptides Grant 10,202,452 - Tan , et al. Feb	2019-02-12
Oncofetal Antigen Binding Proteins And Related Compositions And Methods App 20190016816 - Bienvenue; David ; et al.	2019-01-17
B-cell reduction using CD37-specific and CD20-specific binding molecules Grant 10,143,748 - Grosmaire , et al. De	2018-12-04
Heterodimer Binding Proteins And Uses Thereof App 20180273642 - Blankenship; John W. ; et al.	2018-09-27
Cd3 Binding Polypeptides App 20180273622 - Tan; Philip ; et al.	2018-09-27
Single-chain Multivalent Binding Proteins With Effector Function App 20180118823 - THOMPSON; Peter Armstrong ; et al.	2018-05-03
Prostate-specific Membrane Antigen Binding Proteins And Related Compositions And Methods App 20180100021 - BLANKENSHIP; John W. ; et al.	2018-04-12
Compositions And Methods For Combination Therapy With Prostate-specific Membrane Antigen Binding Proteins App 20180022819 - BLANKENSHIP; John ; et al.	2018-01-25
Prostate-specific Membrane Antigen Binding Proteins And Related Compositions And Methods App 20170306045 - BLANKENSHIP; John W. ; et al.	2017-10-26
Prostate-specific membrane antigen binding proteins and related compositions and methods Grant 9,782,478 - Blankenship , et al. October 10, 2	2017-10-10
Cell Line-based Redirected T-cell Cytotoxicity Assay App 20170089885 - Blankenship; John ; et al.	2017-03-30
Cd86 Antagonist Multi-target Binding Proteins App 20170015747 - Thompson; Peter Armstrong ; et al.	2017-01-19
CD86 antagonist multi-target binding proteins Grant 9,493,564 - Thompson , et al. November 15, 2	2016-11-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.